Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Eli Lilly Stock Could Have a Huge Growth Catalyst in Early 2025
Eli Lilly Stock Could Have a Huge Growth Catalyst in Early 2025
Eli Lilly Stock Could Have a Huge Growth Catalyst in Early 2025
Submitted by
admin
on December 12, 2024 - 11:41pm
Source:
Motley Fool
News Tags:
Eli Lilly
orforglipron
Headline:
Eli Lilly Stock Could Have a Huge Growth Catalyst in Early 2025
snippet:
Eli Lilly expects to have data from a late-stage trial involving orforglipron by April.
This weight loss pill helped patients lose nearly 15% of their weight in a phase 2 trial.
Lilly has been a growth machine, and orforglipron could help it generate even better results.
Do Not Allow Advertisers to Use My Personal information
